Skip to content

Cluster Randomised Controlled Trial of the Serious Mental Illness Health Improvement Profile [HIP]

Cluster Randomised Controlled Trial of the Serious Mental Illness Health Improvement Profile [HIP]

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN41137900
Enrollment
250
Registered
2011-03-04
Start date
2011-04-04
Completion date
Unknown
Last updated
2019-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Mental Health Research Network

Interventions

The HIP Programme - The Serious Mental Illness Physical Health Improvement Profile (HIP) and HIP training package for nurses
Study Entry : Single Randomisation only

Sponsors

Norfolk and Waveney Mental Health NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Registered mental health nurse (MHN) working in a community mental health setting 2. Registered with the Nursing and Midwifery Council [NMC] for at least 6 months 3. Employed at Agenda for Change band 5-7 4. Working in one of the community mental health teamsacross the study sites 5. Has at least 5 patients on their caseload with a primary diagnosis of serious mental illness (SMI) (as confirmed by the Team Leader) Patients: 1. Aged over 18 2. On the caseload of the MHN participant at the start of the project 3. Has a primary diagnosis of SMI (as confirmed by the last recorded diagnosis in the patient record either being schizophrenia, schizoaffective or bipolar disorder as confirmed by the Team Leader).; Target Gender: Male & Female ; Lower Age Limit 18 no age limit or unit specified

Exclusion criteria

Exclusion criteria: Following screening by the Research Assistant, MHNs will not be included if they: 1. Are still in preceptorship following recent Nursing and Midwifery Council [NMC] registration as a MHN 2. Are about to go on maternity leave 3. Are pregnant or up to 6 months post partum Following screening by the Trial Coordinator and the Team Leader patients with SMI will not be included if they: 1. Currently lack the capacity to consent to treatment as documented by a heath professional on Form 4 in their case notes (NWMHFT, 2005) as they would also be considered unable to consent to participation in research. 2. Have a serious or unstable medical condition (e.g. advanced/incurable cancer; severe co-morbidity such as people on renal haemodialysis, end-stage Chronic obstructive pulmonary disease (COPD) and New York Heart Association (NYHA) classification grade 3 or 4 heart failure; severe unpredictable pain) 3. Where the Team Leader considers participation in the trial will put the patient, nurse or research assistant at increased risk or increased cost to the service to manage risk

Design outcomes

Primary

MeasureTime frame
PCS SF-36v2; Timepoint(s): 1 year follow-up

Secondary

MeasureTime frame
1. MCS SF-36v2 2. EQ-5D 3. Levels of health care resource use 4. PHASe (adapted) 5. QRISK®2 6. HIP Audit Form 7. Patient Semi-structured Interview Schedule, Nurse Focus Group Interview 8. Schedule and Psychiatrist/GP Telephone Interview Schedule

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 28, 2026